Molecular Therapy Oncolytics

短名Mol. Ther. Oncolytics
Journal Impact5.28
国际分区ONCOLOGY(Q1)
期刊索引SCI Q2中科院 2 区
ISSN2372-7705
h-index42
国内分区医学(2区)医学医学研究与实验(2区)医学肿瘤学(3区)

MOLECULAR THERAPY — ONCOLYTICS 是一本国际性、仅限在线的开放获取期刊,专注于针对癌症的病毒、细胞和其他生物疗法的开发和临床测试。

期刊主页投稿网址
涉及主题生物遗传学医学内科学癌症研究癌症化学生物化学免疫学基因免疫系统肿瘤细胞病毒学病毒溶瘤病毒细胞生物学病理癌细胞细胞凋亡体外细胞培养免疫疗法细胞
出版信息出版商: Cell Press出版周期: 期刊类型: journal
基本数据创刊年份: 2014原创研究文献占比84.72%自引率:N.A.Gold OA占比: 89.58%
平均审稿周期 网友分享经验:6 Weeks

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges

2023-12-1

A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling

2023-12-1

Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma

2023-12-1

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

2023-12-1

Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases

2023-12-1

Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers

2023-12-1

Molecular Therapy Oncology: What’s in a name?

2023-12-1

An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response

2023-12-1

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma

2023-12-1

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2

2023-12-1

Thank you to our 2023 reviewers

2023-12-1

Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum

2023-12-1

Oncolytic virotherapy targeting the IL15 pathway

2023-12-1

Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment

2023-12-1

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

2023-12-1

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment

2023-12-1

Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 T cell response in colorectal cancer

2023-12-1

Targeting mesothelin in cancer

2023-12-1

Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2

2023-12-1

New advances in cancer therapy targeting TGF-β signaling pathways

2023-12-1

Gaining insights into virotherapy with canine models

2023-12-1

Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer

2023-12-1

miR-146a: Overcoming coldness in ovarian cancer

2023-12-1

Targeting the lactic acid metabolic pathway for antitumor therapy

2023-12-1

Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer

2023-12-1

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

2023-11-20

Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products

2023-11-10

Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy

2023-11-4

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

2023-10-23

Advancements in CRISPR screens for the development of cancer immunotherapy strategies

2023-10-5

Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate

2023-9-13

miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration

2023-9-13

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions

2023-9-1

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma

2023-9-1

Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models

2023-9-1

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers

2023-9-1

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors

2023-9-1

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice

2023-9-1

Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer

2023-9-1

Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy

2023-9-1

JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis

2023-9-1

Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection

2023-9-1

Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution

2023-9-1

Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives

2023-9-1

A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon

2023-9-1

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

2023-9-1

Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL

2023-9-1

Dynamic fine-tuning of CAR-T cell therapy

2023-9-1

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

2023-9-1

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment

2023-9-1

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司